Relationship between infarct size and serum uric acid levels during the acute phase of stroke
Open Access
- 11 July 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (7) , e0219402
Abstract
Uric acid has gained considerable attention as a potential neuroprotective agent in stroke during the last decades, however, its role in the pathophysiology of ischemic stroke remains poorly understood. A serial evaluation of uric acid levels during the acute phase of stroke and its association with infarct size on magnetic resonance imaging is lacking. We present a cohort study of 31 patients with ischemic stroke who were not candidates for thrombolysis according to current criteria at the time. We performed daily measurements of serum uric acid and total antioxidant capacity of plasma during the first week after symptoms onset and 30 days after. Infarct size was determined in the acute phase by a DWI sequence and the final infarct size with a control MRI (FLAIR) at day 30. Uric acid significantly decreases between days 2 to 6 compared to day 1, after adjustment by sex, age and DWI at diagnosis, with a nadir value at 72h. A mixed model analysis showed a negative association between DWI at diagnosis and uric acid evolution during the first week after stroke. Moreover, multivariable linear regression of uric acid values during follow up on DWI volumes demonstrated that DWI volume at diagnosis is negatively associated with uric acid levels at day 3 and 4. There were no significant associations between total antioxidant capacity of plasma and DWI at diagnosis, or FLAIR at any point. Patients with larger infarcts exhibited a significant decrease in serum uric acid levels, accounting for a more prominent reactive oxygen species scavenging activity with subsequent consumption and decay of this antioxidant. The different kinetics of total antioxidant capacity of plasma and serum uric acid levels suggests a specific role of uric acid in the antioxidant response in ischemic stroke.Keywords
Funding Information
- FONDECYT (1120594)
- Fondo de Fomento al Desarrollo Científico y Tecnológico (ID15I10285)
- Clínica Santa María
This publication has 23 references indexed in Scilit:
- Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studiesAtherosclerosis, 2014
- Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø StudyBMC Cardiovascular Disorders, 2013
- Uric Acid Levels Are Relevant in Patients With Stroke Treated With ThrombolysisStroke, 2011
- Uric acid transport and diseaseJournal of Clinical Investigation, 2010
- Uric Acid Reduces Brain Damage and Improves the Benefits of rt-PA in a Rat Model of Thromboembolic StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- Prognostic Significance of Uric Acid Serum Concentration in Patients With Acute Ischemic StrokeStroke, 2002
- Antioxidant Profile and Early Outcome in Stroke PatientsStroke, 2000
- Serum Uric Acid and Cardiovascular MortalityJAMA, 2000
- Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivoJournal of Neuroscience Research, 1998
- Towards the physiological function of uric acidFree Radical Biology and Medicine, 1993